{"id":"W1615450578","doi":"","title":"CIMAvax-EGF: A novel therapeutic vaccine for advanced lung cancer","year":2009,"lang":"en","type":"article","venue":"DOAJ (DOAJ: Directory of Open Access Journals)","topic":"vaccines and immunoinformatics approaches","field":"Biochemistry, Genetics and Molecular Biology","cited_by":8,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Clinical trial; Lung cancer; Medicine; Negotiation; Product (mathematics); Quality (philosophy); Immunogenicity; Agency (philosophy); Biosimilar; Business; Oncology; Political science; Internal medicine; Immunology; Immune system; Sociology","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004743771,0.0003265515,0.0005409403,0.0002027969,0.0001964635,0.0004212736,0.00161624,0.0001446531,0.0005429822],"category_scores_gemma":[0.00009517646,0.0002766984,0.0002469127,0.0003215154,0.00002354089,0.0001391298,0.0003283645,0.0001738959,0.00000122087],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003987817,"about_ca_system_score_gemma":0.0001423115,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00005921152,"about_ca_topic_score_gemma":0.000016027,"domain_scores_codex":[0.9982396,0.00003301687,0.0007199812,0.0003510824,0.0002383485,0.0004180198],"domain_scores_gemma":[0.9983703,0.00003872081,0.0006246789,0.0005120157,0.0003178513,0.0001364275],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0006339318,0.000245253,0.01484471,0.00009488534,0.0003086992,6.93453e-7,0.00006241891,0.0005728998,0.9248598,0.00009023886,0.01538659,0.04289991],"study_design_scores_gemma":[0.005657519,0.0001998025,0.3144823,0.000416349,0.0003281854,0.00003128168,0.0001551527,0.003139206,0.5875552,0.001990567,0.0848147,0.001229774],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8884409,0.09309301,0.01391294,0.0007059663,0.0005001607,0.001386449,0.0001228267,0.00002274196,0.001815003],"genre_scores_gemma":[0.979483,0.01674302,0.001475138,0.001272567,0.0002647747,0.0001220702,0.00007950041,0.00004886452,0.0005110835],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3373046,"threshold_uncertainty_score":0.9999685,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1401483828248797,"score_gpt":0.5202841043855145,"score_spread":0.3801357215606348,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}